The beneficial effects of high dose glucose-insulinpotassium (GIK) infusion have been reported in reperfused patients after by pass graft surgery [1] , in stable coronary artery disease [2] , after acute myocardial infarction [3, 4] and during pacing stress testing [5] . GIK exert beneficial effects on the ischaemic heart by reducing infarct size, improving post ischaemic left ventricular function and reducing mortality in myocardial infarction by 28 % [6] .
injury, enhanced protein efflux and increased leukocyte and platelet adhesion in postcapillary venules [7±10] .
Furthermore, the haemodynamic effects of hyperglycaemia and hyperinsulinaemia in microcirculation in normal and ischaemic conditions are not clear. Studies show that insulin causes vasodilation in cheek pouch microcirculation [11] while hyperglycaemia modifies the reaction of vessels to insulin in rat skeletal muscle [12] . There is also a direct vasodilatory effect of physiological hyperinsulinaemia in human skeletal muscle [13] and an increase in coronary blood flow with acute GIK infusion in human beings [14] . Insulin is crucial in the regulation of local microvascular perfusion because the insulin-induced increase in blood flow is mediated by nitric oxide (NO) as shown in isolated skeletal muscle arterioles [15] and in the human forearm [16] .
Accumulating evidence indicates that oxygen free radicals have been implicated in tissue injury that follows I/R [9, 17, 18] . Dipyridamole, that blocks adenosine transport and determines endogenous adenosine accumulation protects reperfused myocardium of perfused rat heart and improves myocardial contractictility of postischaemic myocardium [19±22] . Adenosine has been shown to have an antioxidant effect thus avoiding the production of oxygen free radicals by high insulin and hyperglycaemia [23, 24] . Furthermore, oxidative stress impairs insulin endocytosis in endothelial cells of both arterioles and venules [25] . This was not a consequence of the modified insulin binding capacity but could involve insufficient insulin receptor activation [26] .
We hypothesized that insulin response to GIK infusion might lead to vasodilation thus improving capillary perfusion against I/R in cheek pouch microcirculation. Because oxidative stress by GIK causes microvascular dysfunction, we investigated the effects of GIK plus dipyridamole. We measured the arteriolar responses, the red blood cell (RBC) velocity, the functional capillary length (perfused capillary length, PCL), the leukocyte and platelet adhesion and the permeability changes induced by GIK or GIKD infusion during I/R.
Materials and methods
Male Syrian hamsters (80±100 g, Charles River, Calco, Lc Italy) were anaesthetised by intraperitoneal injections of sodium pentobarbital, 50 mg´kg ±1 body wt. The hamsters were tracheotomized and the right carotid artery and femoral vein were cannulated to measure blood pressure. Animal handling and care followed the procedures outlined in the Guide for the Care and Use of the Laboratories of the Italian Research Council.
Experimental groups. The control (I/R) (n = 7) group received an intravenous infusion of saline (0.2 ml/100 g/h). The GIK (n = 7) group was intravenously treated with continuous infusion of GIK (glucose 300 g/l; insulin 50 U/l potassium 80 meq/ l) infused at 0.2 ml´100 g ±1´h±1 ). GIKD (n = 7) group was infused with GIK plus dipyridamole (Persantin, Boheringer Ingelheim s. p. a., Milan, Italy) (0.084 mg´100 g ±1 injected intravenously at baseline and at the beginning of reperfusion). Immediately after baseline systemic measurements (15 min) saline or GIK or GIKD were infused by using a micropump for 15 min in control conditions, and throughout the 15 min of ischaemia and the 30 min of reperfusion. Insulinaemia and glycaemia were determined before saline, GIK, or GIKD infusion and after reperfusion using a glucose oxidase method (Beckman, Fullerton, Calif., USA) and a radioimmunoassay method (Linco Res, St. Charles, Miss., USA), respectively.
Experimental protocol. The cheek pouch was surgically prepared as previously reported [9, 10] . The cheek pouch was gently turned inside out and fixed to a special stage of the microscope and a thin black blade was inserted through a small incision between the upper and lower layers of the pouch. The membrane was suffused with a 36 0.5 C Ringer's solution (4 ml/min), with 5 % CO 2 in 95 % N 2 adjusted to pH 7.35.
Atraumatic microvascular clips were placed on the proximal part of the cheek pouch to achieve complete ischaemia for 30 min. The clamp was then removed and the microcirculation was observed after 30 min.
Observations were made with a fluorescent microscope (Orthoplan, Leica Microsystem GmbH, Wetzlar, Germany) and a filter block (Ploempak, Leica Microsystem GmbH, Wetzlar Germany) fitted with a long working distance objective ( 4, na 0.14,´20, na 0.25) and a 10 eyepiece. Epi-illumination was provided by a xenon 150-W lamp using the appropriate filters for fluorescein isothiocyanate bound to dextran MW 150,000 (Sigma Chemical, St. Louis, Miss., USA) (50 mg/ 100 g b. wt., intravenously injected as 5 % W/V solution in 5 min) (Leitz I 2 ), for acridine red (Leitz N 2 ) and a heat filter (Leitz KG1). The area of interest was televised with a COHU 5253 SIT low light level camera, observed from a Sony PVM 122 CE monitor. Video images were videotaped and microvascular measurements were made off-line by a computer-assisted imaging software system (MIP Image, CNR, Institute for Clinical Physiology, Pisa, Italy).
Measurements of microvascular parameters. The animals of all the groups received an intravenous injection of acridine red (1 mg/100 g) to visualize the leukocytes and the platelets at baseline and after reperfusion. The number of adherent leukocytes was expressed as the number per 100 mm length of venule (diameters: 16 8 mm, length > 250 mm). The number of adherent platelets was expressed as number per mm 2 of vessel surface (diameters: 16 8 mm). In each animal five arterioles and five venules were recorded on videotape.
PCL, defined as the length of capillaries that have a RBC transit of at least one RBC in a 30 s period, was analysed from four to six different microscopic fields. Microvessel diameters were measured by an image shearing system (Digital Image Shearing Monitor Mod 907, I. P. M., San Diego, Calif., USA). Red blood cell (RBC) velocity was determined using dual slit cross correlation (velocity tracker Mod 102 B, I. P. M., San Diego, Calif., USA).
To quantify the permeability across the venules the values fluorescence intensity in the perivascular space were reported as normalized to baseline grey levels: NGL = (I±I r )/I r , where I is the average baseline grey level and I r is the same parameter after reperfusion [9 ] . Grey levels, ranging from 0 to 255, were determined by the MIP Image program. The windows to measure average fluorescence intensity were set at 50 mm long and 50 mm wide.
RBC velocity was determined using dual slit cross correlation (velocity tracker Mod 102 B, I. P. M., San Diego, Calif., USA). The measured centreline velocity was corrected according to vessel size to obtain the mean RBC velocity. The video image shearing technique was used to measure vessel diameter on-line.
Mean arterial blood pressure (MAP) (Viggo-Spectramed P10E2 transducer, Oxnard, Calif., USA) and heart rate (HR) were measured by a Gould Windograf recorder (Mod. 13±6615±10S Gould Instruments System GmbH, Dietzenbach, Germany).
All reported values are means SEM. Due to the limited number of animals non-parametric tests were used. We used the Kruskal-Wallis test for analysis between groups. A p value of less than 0.05 was considered to be statistically significant.
Results
MAP and HR did not change significantly after reperfusion in comparison with the baseline (Table 1) . GIK and GIKD groups showed a significantly higher level of insulinaemia and glycaemia in comparison with the baseline and I/R group. Insulinaemia increased after 15 min compared with saline injection (Table 1) .
In I/R group the arteriolar diameter decreased after reperfusion in comparison with the baseline (p < 0.001) whereas the venules dilated slightly. The changes in the diameter of A1 and A2 (range, 18±50 mm) and small collecting and large venules, Vc and VL (range 37±115 mm) measured at baseline and after reperfusion are shown in Figure 1 . RBC velocity decreased in arterioles after reperfusion (1.98 0.35 mm/s at baseline, p < 0.01) (Fig. 2) . These changes were associated with a marked permeability increase in postcapillary and collecting venules after reperfusion (baseline: 0.09 0.01 normalized grey levels, p < 0.01) (Fig. 1) . PCL decreased by 47 3 % of baseline (9,130 430 mm) (p < 0.01) (Fig. 2) . The number of leukocytes adhering to the venular wall increased after reperfusion (p < 0.01) (Fig. 3) . The platelets adhering to microvessels and to arterioles increased significantly in comparison with baseline (Fig. 4) .
In GIK group, arterioles did not constrict at reperfusion (Fig. 1) . Under baseline conditions arteriolar diameter were mostly constant during the observation period whereas irregular arteriolar vasomotion appeared in control conditions during GIK infusion. During the period of ischaemia, some irregular contraction and dilation of arterioles caused a backward and forward flow in the network. A significant increase in diameter and RBC velocity in arterioles was present from the beginning of the reperfusion but did not persist to the end. The permeability de- Values are means SEM *p < 0.05 when compared with control group (I/R) Fig. 1 . Changes (%) of diameter of arterioles ( ) and venules ( ), and arteriolar RBC velocity (&&), and permeability levels (&), at baseline in control (I/R), glucose-insulin potassium (GIK) and glucose-insulin-potassium-dipyridamole (GIKD) treated groups at baseline and 30 min of reperfusion. Data are means SEM, *p < 0.05 vs baseline, p < 0.01. vs I/R; **p < 0.01 vs GIK
Fig 2.
Changes (%) of perfused capillary length (PCL) at baseline (Bsln), in the control (I/R) group treated with saline, glucose-insulin-potassium (GIK), glucose-insulin-potassium infusion plus dipyridamole (GIKD), respectively, at reperfusion. Means SD, *p < 0.01 vs baseline, p < 0.01 vs I/R; **p < 0.01 vs GIK creased in comparison with I/R group but there were some leakages in the postcapillary venules (Fig. 1) . PCL increased significantly in comparison with the control group whereas it decreased in comparison with the baseline (8950 780 mm) (Fig. 2) . GIK reduced the number of adherent leukocytes by 56 % at reperfusion in comparison with I/R group (Fig. 3) . The platelets adhering to microvessels and to arterioles decreased by 52 % in comparison with I/R group (Fig. 4) .
In the GIKD group arterioles dilated significantly during the period of reperfusion and the RBC velocity increased significantly in arterioles at reperfusion (p < 0.01) (Fig. 1) . These changes were associated with no permeability increase in postcapillary and collecting venules. The PCL increased in comparison with the control group whereas it was not reduced after I/R in comparison with baseline (10 250 550 mm) (Fig. 2) . The number of leukocytes adhering to the venular wall decreased by 86 % at reperfusion in comparison with I/R group (Fig. 3) . The platelets adhering to microvessels and to arterioles decreased by 72 % in comparison with I/R group (Fig. 4) .
Discussion
The main result of our findings is that GIK infusion attenuated the microvascular changes induced by I/ R when used in association with dipyridamole which caused arteriolar vasodilation and consequently determined a significant increase in the capillary perfusion. The I/R injury caused arterial vasoconstriction that was suppressed by functional changes induced by hyperglycaemia and hyperinsulinaemia. However, the increase in the capillary perfusion was lower than in GIKD group. The increase in capillary perfusion could be essential in the mechanism of protection, thus determining glucose and oxygen delivery to the tissue and permitting the extraction of by products of cellular metabolism during reperfusion. The beneficial effects of dipyridamole seem to derive from a more marked reduction of leukocyte and platelet adhesion via the inhibition of oxygen free radical formation.
Our findings show that hyperglycaemia and hyperinsulinaemia inhibited the arterial vasoconstriction during ischaemia and improved the capillary perfusion at 30 min of reperfusion. Previously, we showed that insulin caused vasodilation in cheek pouch microcirculation in control conditions [11] whereas there is a different effect of hyperglycaemia and hyperinsulinaemia on the vascular endothelium during I/R; namely there is no vasodilation during reperfusion and blood flow is reduced below baseline after reperfusion. In healthy individuals, insulin administration caused an increase in blood flow which is dependent on the effect of insulin on the vascular endothelium that could cause increased production of NO [13] . Furthermore, hyperglycaemia modified the reaction of microvessels to insulin and increased arteriolar vasomotion in rat skeletal muscle [12] .
During ischaemia the arteriolar tone improved after insulin injection and this should have additional and beneficial effects thus avoiding the endothelium impairment and re-establishing the shear stress mechanism on the vessel wall during the early period of reperfusion. Hyperinsulinaemia and hyperglycaemia might maintain a normal vascular reactivity thus permitting an increase in flow with increased vasodilation in association with dipyridamole injection.
Our data show that there was a significant reduction in leukocyte adhesion to venules with a significant increase in arteriolar and capillary RBC velocity Fig. 3 . Number of adherent leukocytes/100 mm venules in the groups treated with saline (I/R), with glucose-insulin-potassium (GIK) and GIK infusion plus-dipyridamole (GIKD), respectively, at baseline and 30 min of reperfusion. Means SEM, n = 25 for each entry *p < 0.01 vs baseline, p < 0.01. vs I/R; **p < 0.01 vs GIK Fig. 4 . Number of adherent platelets/mm 2 of vessel surface at baseline and after reperfusion in the control group (I/R) and those treated with glucose-insulin-potassium (GIK) and insulin-glucose infusion plus-dipyridamole (GIKD), respectively, at baseline and 30 min of reperfusion. Means SEM, n = 25 experimental observations for each entry, *p < 0.01 vs baseline, p < 0.01. vs I/R; **p < 0.01 vs GIK in hamster treated with GIK infusion and dipyridamole. The interaction of leukocytes with endothelial cells dramatically increase the oxygen-free radical formation especially in the latter part of reperfusion [18] . The beneficial microvascular protection might come from relief from oxidative stress, synergistically achieved by the addition of dipyridamole with its scavenger effect. There are several reports that provide evidence that adenosine acts as an antiflammatory agent. This evidence is largely based on observation that adenosine inhibits O 2±´a nd H 2 O 2 production by PMNs [27] . Previously, it has been shown that insulin decreases circulating vitamin E levels in humans during the euglycaemic hyperinsulinaemic clamp thus suggesting that high level of insulin increases ROS production [24] . In accordance with our data, insulin and dipyridamole have been observed to be protective on cultured central nervous system neurons, and more specifically, the antioxidant properties of dipyridamole were suggested to be protective [28] . Dipyridamole increases endogenous adenosine but it has a direct antioxidant effect and also acts via adenosine independent pathways, including inhibition of phosphodiesterases, blockade of chloride transport, interference with the multidrug resistance protein, and enhancement of prostacyclin synthesis [28] . Adenosine also has protective effects in patients as an adjunct to thrombolytic therapy for acute myocardial infarction in multicentre, randomized, placebo-controlled trial [29] .
In agreement with our data, platelet-endothelial interactions have been observed in arterioles during I/R and not just in postcapillary venules [30] . Our data show that there is a decrease of platelet adhesion during GIK infusion in arterioles but the decrease is much more evident in GIKD group. The decreased perfusion in the capillary network during reperfusion might be related to platelet adhesion in arterioles. The adhesion of platelets to the arteriolar endothelim might impede restoration of blood flow by occlusion of the vascular lumen or by the release of vasoconstrictive platelet mediators [30] . Platelets are not activated by hyperglycaemia and hypersulinaemia [31] . However, the PKC is sensitive to oxidation and could be up-regulated during the oxidative stress caused by I/R. It was shown that many proaggregatory stimuli such as the oxidative stress might activate PKC that play an important role in platelet activation [32] .
Therefore, the protective effects of dipyridamole might determine the inhibition of platelet adhesion in the arterioles as well as the inhibition of the following vasoconstriction and reduced capillary perfusion.
In conclusion, this study provides evidence that GIK, when used in combination with dipyridamole, had beneficial effects on capillary perfusion against I/R-induced injury. Hyperglycaemia and hyperinsulinaemia caused no vasodilation and less capillary perfusion. There was also a marked reduction of leukocyte and platelet adhesion in response to the antioxidant properties of dipyridamole. We suggest that the hyperglycaemia and hyperinsulinaemia during GIK infusion is less beneficial than when used in combination with dipyridamole which has specific haemodynamic effects on the microcirculation. Insulin can improve capillary perfusion but not all the microvascular changes induced by I/R.
These results focus on the microcirculation changes as an important potential target of the therapeutic beneficial effects of GIK infusion used in combination with dipyridamole to avoid microvascular damage and afford protection against I/R.
